Clinical trial · Interventional
Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer
Fish Oil Supplementation in Cancer Patients - Capsules or in Nutritional Supplements. A Controlled Trial of Compliance.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Several studies indicate beneficial effects of eicosapentanoic acid (EPA) on cancer cachexia. However, compliance is generally low. This case control study is conducted in order to investigate if compliance depends upon the physical properties of the supplement (capsules vs. drinks). In order to further investigate how compliance can be improved, a possible correlation between sideeffects and rate of increased polyunsaturated fatty acid concentration in blood is also tested
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Abdominal Cancer | Malignant Abdominal Neoplasm | ALIAS | 0.90 |
| Compliance | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Möllers Omega-3 Ekstra Sterk | Dietary Supplement | — | UNRESOLVED |
| Nutrifriend Cachexia | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Capsules
- description
- Dietary Supplement: Möllers Omega-3 Ekstra Sterk
- interventionNames
- Dietary Supplement: Möllers Omega-3 Ekstra Sterk
- type
- ACTIVE_COMPARATOR
- label
- Drink
- description
- Dietary Supplement: Nutrifriend Cachexia
- interventionNames
- Dietary Supplement: Nutrifriend Cachexia
Primary outcomes (1)
- measure
- Compliance
- timeFrame
- 4 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients receiving chemotherapy on Rigshospitalet due to colorectal cancer * Not terminally ill * Subjects must be18 years of age (or older) Exclusion Criteria: * Subjects who do not read/speak/understand Danish * Familial hypercholesterolemia * Predialytic patients (GFR \< 15 ml/min/1,73 m2 or creatinine ≥ 500 mmol/L) * Use of blood thinners * Bleeder's disease
References
Publications (1)
- DERIVEDSchmidt N, Moller G, Baeksgaard L, Osterlind K, Stark KD, Lauritzen L, Andersen JR. Fish oil supplementation in cancer patients. Capsules or nutritional drink supplements? A controlled study of compliance. Clin Nutr ESPEN. 2020 Feb;35:63-68. doi: 10.1016/j.clnesp.2019.12.004. Epub 2020 Jan 3. PMID 31987122